Appl Microbiol Biotechnol (2010) 86:1067–1075 Brignole C, Pastorino F, Marimpietri D, Pagnan G, Pistorio A, Allen TM, Pistoia V, Ponzoni M (2004) Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs. J Natl Cancer Inst 96:1171–1180 Cheresh DA (1987) Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci U S A 84:6471–6475 Corey DR (2007) RNA learns from antisense. Nat Chem Biol 3:8–11 Dorsett Y, Tuschl T (2004) siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3:318–329 Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR (1989) Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61–68 Hu G, Xu ZK, Zhang FL, Wu XA, Yan Y, Bai WT, Yu L, Wang HT (2005) Expression of recombinant baculovirus carrying chimeric gene of a diabody against hantaan virus in insect cells. Mian Yi Xue Za Zhi. 21(2):84–87 Hynes RO (1992) Integrins: versatility, modulation and signaling in cell adhesion. Cell 69:11–25 Jackson JR, Sathe G, Rosenberg M, Sweet R (1995) In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta. J Immunol 154:3310–3319 Joliot A, Prochiantz A (2004) Transduction peptides: from technology to physiology. Nat Cell Biol 6:189–196 LaVallie ER, McCoy JM (1995) Gene fusion expression systems in Escherichia coli. Curr Opin Biotechnol 6:501–506 Linderholm M, Elgh F (2001) Clinical characteristics of hantavirus infections on the Eurasian continent. Curr Top Microbiol Immunol 256:135–151 Lindgren M, Hällbrink M, Prochiantz A, Langel U (2000) Cell- penetrating peptides. Trends Pharmacol Sci 21:99–103 Liu B (2007) Exploring cell type-specific internalizing antibodies for targeted delivery of siRNA. Brief Funct Genomic Proteomic 6:112–119 López N, Padula P, Rossi C, Lázaro ME, Franze-Fernández MT (1996) Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 220:223–226 Luo W, Yan Y, Xu ZK, Zhang FL, Wu XA, Liu Y, Bai WT, Wang HT (2003) Construction and sequence analysis of single-chain Fv antibody fragment 3G1. Xi An Lian He Da Xue Xue Bao 6(2):5–8 Mellman I (1996) Membranes and sorting. Curr Opin Cell Biol 8:497– 498 Meyer BJ, Schmaljohn CS (2000) Persistent hantavirus infections: characteristics and mechanisms. Trends Microbiol 8:61–67 Moura-da-Silva AM, Línica A, Della-Casa MS, Kamiguti AS, Ho PL, Crampton JM, Theakston RD (1999) Jararhagin ECD-containing disintegrin domain: expression in Escherichia coli and inhibition of the platelet-collagen interaction. Arch Biochem Biophys 369:295–301 Nichol ST, Spiropoulou CF, Morzunov S, Rollin PE, Ksiazek TG, Feldmann H, Sanchez A, Childs J, Zaki S, Peters CJ (1993) Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 262:914–917 Ogino M, Yoshimatsu K, Ebihara H, Araki K, Lee BH, Okumura M, Arikawa J (2004) Cell fusion activities of Hantaan virus envelope glycoproteins. J Virol 78:10776–10782 1075 Peer D, Zhu P, Carman CV, Lieberman J, Shimaoka M (2007) Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc Natl Acad Sci U S A 104:4095–4100 Peters CJ, Simpson GL, Levy H (1999) Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 50:531–545 Pirollo KF, Zon G, Rait A, Zhou Q, Yu W, Hogrefe R, Chang EH (2006) Tumor-targeting nanoimmunoliposome complex for short interfering RNA delivery. Hum Gene Ther 17:117–124 Pirollo KF, Rait A, Zhou Q, Hwang SH, Dagata JA, Zon G, Hogrefe RI, Palchik G, Chang EH (2007) Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. Cancer Res 67:2938–2943 Plyusnin A, Vapalahti O, Vaheri A (1996) Hantaviruses: genome structure, expression and evolution. J Gen Virol 77:2677–2687 Schier R, McCall A, Adams GP, Marshall KW, Merritt H, Yim M, Crawford RS, Weiner LM, Marks C, Marks JD (1996) Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J Mol Biol 263:551–567 Schmaljohn CS, Dalrymple JM (1983) Analysis of Hantaan virus RNA: evidence for a new genus of bunyaviridae. Virology 131:482– 491 Schmaljohn C, Hjelle B (1997) Hantaviruses: a global disease problem. Emerg Infect Dis 3:95–104 Sjölander KB, Golovljova I, Vasilenko V, Plyusnin A, Lundkvist A (2002) Serological divergence of Dobrava and Saaremaa hanta- viruses: evidence for two distinct serotypes. Epidemiol Infect 128:99–103 Song G (1999) Epidemiological progresses of hemorrhagic fever with renal syndrome in China. Chin Med J (Engl) 112:472–477 Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y, Palliser D, Weiner DB, Shankar P, Marasco WA, Lieberman J (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23:709–717 Sorkin A, Von Zastrow M (2002) Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol 3:600– 614 Wen WH, Liu JY, Qin WJ, Zhao J, Wang T, Jia LT, Meng YL, Gao H, Xue CF, Jin BQ, Yao LB, Chen SY, Yang AG (2007a) Targeted inhibition of HBV gene expression by single-chain antibody mediated small interfering RNA delivery. Hepatology 46:84– 94 Wen WH, Qin WJ, Gao H, Zhao J, Jia LT, Liao QH, Meng YL, Jin BQ, Yao LB, Chen SY, Yang AG (2007b) An hepatitis B virus surface antigen specific single chain of variable fragment derived from a natural immune antigen binding fragment phage display library is specifically internalized by HepG2.2.15 cells. J Viral Hepat 14:512–519 Wu SC, Yu CH, Lin CW, Chu IM (2003) The domain III fragment of Japanese encephalitis virus envelope protein: mouse immunoge- nicity and liposome adjuvanticity. Vaccine 21:2516–2522 Yang WP, Green K, Pinz-Sweeney S, Briones AT, Burton DR, Barbas CF 3rd (1995) CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J Mol Biol 254:392–403